BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31279989)

  • 1. Preliminary study: Breast cancers can be well seen on 3T breast MRI with a half-dose of gadobutrol.
    Melsaether AN; Kim E; Mema E; Babb J; Kim SG
    Clin Imaging; 2019; 58():84-89. PubMed ID: 31279989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Efficacy of Reduced-Dose Gadobutrol Versus Standard-Dose Gadoterate for Contrast-Enhanced MRI of the CNS: An International Multicenter Prospective Crossover Trial (LEADER-75).
    Liu BP; Rosenberg M; Saverio P; Weon YC; Peters S; Ardellier FD; Boeckenhoff A; Endrikat J
    AJR Am J Roentgenol; 2021 Nov; 217(5):1195-1205. PubMed ID: 34133205
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of gadobutrol on background parenchymal enhancement and differential diagnosis between benign and malignant lesions in dynamic magnetic resonance imaging of the breast.
    Tozaki M; Yabuuchi H; Goto M; Sasaki M; Kubota K; Nakahara H
    Breast Cancer; 2021 Jul; 28(4):927-936. PubMed ID: 33625722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadobutrol-Enhanced Magnetic Resonance Imaging of the Breast in the Preoperative Setting: Results of 2 Prospective International Multicenter Phase III Studies.
    Sardanelli F; Newstead GM; Putz B; Jirakova Trnkova Z; Trimboli RM; Abe H; Haverstock D; Rosenberg M
    Invest Radiol; 2016 Jul; 51(7):454-61. PubMed ID: 26840494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Half-Dose Gadopiclenol versus Full-Dose Gadobutrol for Contrast-enhanced Body MRI.
    Kuhl C; Csőszi T; Piskorski W; Miszalski T; Lee JM; Otto PM
    Radiology; 2023 Jul; 308(1):e222612. PubMed ID: 37462494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrafast Dynamic Contrast-Enhanced Breast MRI: Lesion Conspicuity and Size Assessment according to Background Parenchymal Enhancement.
    Kim SY; Cho N; Choi Y; Shin SU; Kim ES; Lee SH; Chang JM; Moon WK
    Korean J Radiol; 2020 May; 21(5):561-571. PubMed ID: 32323501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Breast Cancer Detection as a Stand-Alone Parameter: Comparison With Dynamic Contrast-Enhanced and Multiparametric Magnetic Resonance Imaging.
    Pinker K; Moy L; Sutton EJ; Mann RM; Weber M; Thakur SB; Jochelson MS; Bago-Horvath Z; Morris EA; Baltzer PA; Helbich TH
    Invest Radiol; 2018 Oct; 53(10):587-595. PubMed ID: 29620604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy and inter-reader agreement of breast MRI for cancer staging using 0.08 mmol/kg of gadobutrol.
    Cozzi A; Buragina G; Spinelli D; Schiaffino S; Zanardo M; Di Leo G; Carbonaro LA; Sardanelli F
    Clin Imaging; 2021 Apr; 72():154-161. PubMed ID: 33249403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic magnetic resonance imaging of the breast: Comparison of gadobutrol vs. Gd-DTPA.
    Escribano F; Sentís M; Oliva JC; Tortajada L; Villajos M; Martín A; Ganau S
    Radiologia (Engl Ed); 2018; 60(1):49-56. PubMed ID: 29217300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of breast MRI for patients with a biopsy showing atypical ductal hyperplasia (ADH).
    Tsuchiya K; Mori N; Schacht DV; Sheth D; Karczmar GS; Newstead GM; Abe H
    J Magn Reson Imaging; 2017 Dec; 46(6):1738-1747. PubMed ID: 28295791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apparent diffusion coefficient values may help predict which MRI-detected high-risk breast lesions will upgrade at surgical excision.
    Cheeney S; Rahbar H; Dontchos BN; Javid SH; Rendi MH; Partridge SC
    J Magn Reson Imaging; 2017 Oct; 46(4):1028-1036. PubMed ID: 28181343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of gadoteric acid and gadobutrol for detection as well as morphologic and dynamic characterization of lesions on breast dynamic contrast-enhanced magnetic resonance imaging.
    Renz DM; Durmus T; Böttcher J; Taupitz M; Diekmann F; Huppertz A; Pfeil A; Maurer MH; Streitparth F; Bick U; Hamm B; Fallenberg EM
    Invest Radiol; 2014 Jul; 49(7):474-84. PubMed ID: 24637587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast lesion detection and characterization with contrast-enhanced magnetic resonance imaging: Prospective randomized intraindividual comparison of gadoterate meglumine (0.15 mmol/kg) and gadobenate dimeglumine (0.075 mmol/kg) at 3T.
    Clauser P; Helbich TH; Kapetas P; Pinker K; Bernathova M; Woitek R; Kaneider A; Baltzer PAT
    J Magn Reson Imaging; 2019 Apr; 49(4):1157-1165. PubMed ID: 30552829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of automated breast volume scanner (ABVS) for monitoring tumor response to neoadjuvant treatment in breast cancer patients: preliminary results.
    D'Angelo A; Rinaldi P; Belli P; D'Amico R; Carlino G; Grippo C; Giuliani M; Orlandi A; Infante A; Manfredi R
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):225-231. PubMed ID: 30657564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-to-Dose Relationship of Gadopiclenol, an MRI Macrocyclic Gadolinium-based Contrast Agent, Compared with Gadoterate, Gadobenate, and Gadobutrol in a Rat Brain Tumor Model.
    Robert P; Vives V; Grindel AL; Kremer S; Bierry G; Louin G; Ballet S; Corot C
    Radiology; 2020 Jan; 294(1):117-126. PubMed ID: 31660804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal liver lesions: detection and characterization at double-contrast liver MR Imaging with ferucarbotran and gadobutrol versus single-contrast liver MR imaging.
    Heilmaier C; Lutz AM; Bolog N; Weishaupt D; Seifert B; Willmann JK
    Radiology; 2009 Dec; 253(3):724-33. PubMed ID: 19789232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical application of bilateral high temporal and spatial resolution dynamic contrast-enhanced magnetic resonance imaging of the breast at 7 T.
    Pinker K; Bogner W; Baltzer P; Trattnig S; Gruber S; Abeyakoon O; Bernathova M; Zaric O; Dubsky P; Bago-Horvath Z; Weber M; Leithner D; Helbich TH
    Eur Radiol; 2014 Apr; 24(4):913-20. PubMed ID: 24306425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-enhanced spectral mammography vs. mammography and MRI - clinical performance in a multi-reader evaluation.
    Fallenberg EM; Schmitzberger FF; Amer H; Ingold-Heppner B; Balleyguier C; Diekmann F; Engelken F; Mann RM; Renz DM; Bick U; Hamm B; Dromain C
    Eur Radiol; 2017 Jul; 27(7):2752-2764. PubMed ID: 27896471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of 3.0-T MRI Brain Signal after Exposure to Gadoterate Meglumine in Women with High Breast Cancer Risk and Screening Breast MRI.
    Bennani-Baiti B; Krug B; Giese D; Hellmich M; Bartsch S; Helbich TH; Baltzer PAT
    Radiology; 2019 Dec; 293(3):523-530. PubMed ID: 31638488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of contrast-enhanced digital mammography and contrast enhanced tomosynthesis--Comparison to contrast-enhanced breast MRI.
    Chou CP; Lewin JM; Chiang CL; Hung BH; Yang TL; Huang JS; Liao JB; Pan HB
    Eur J Radiol; 2015 Dec; 84(12):2501-8. PubMed ID: 26456307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.